Literature DB >> 21946510

Epilepsy surgery of the cingulate gyrus and the frontomesial cortex.

Marec von Lehe1, Jan Wagner, Joerg Wellmer, Hans Clusmann, Thomas Kral.   

Abstract

BACKGROUND: Epilepsy surgery involving the cingulate gyrus has been mostly presented as case reports, and larger series with long-term follow-up are not published yet.
OBJECTIVE: To report our experience with focal epilepsy arising from the cingulate gyrus and surrounding structures and its surgical treatment.
METHODS: Twenty-two patients (mean age, 36; range, 12-63) with a mean seizure history of 23 years (range, 2-52) were retrospectively analyzed. We report presurgical diagnostics, surgical strategy, and postoperative follow-up concerning functional morbidity and seizures (mean follow-up, 86 months; range, 25-174).
RESULTS: Nineteen patients showed potential epileptogenic lesions on preoperative magnetic resonance imaging (MRI). All patients had noninvasive presurgical workup; 15 (68%) underwent invasive Video-electroencephalogram (EEG)-Monitoring. In 12 patients we performed extended lesionectomy according to MRI; an extension with regard to EEG results was done in 6 patients. In 4 patients, the resection was incomplete because of the involvement of eloquent areas according to functional mapping results. Eight pure cingulate resections (36%, 3 in the posterior cingulate gyrus) and 14 extended supracingular frontal resections were performed. Nine patients experienced temporary postoperative supplementary motor area syndrome after resection in the superior frontal gyrus. Two patients retained a persistent mild hand or leg paresis, respectively. Postoperatively, 62% of patients were seizure-free (International League Against Epilepsy [ILAE] 1), and 76% had a satisfactory seizure outcome (ILAE 1-3).
CONCLUSION: Epilepsy surgery for lesions involving the cingulate gyrus represents a small fraction of all epilepsy surgery cases, with good seizure outcome and low rates of postoperative permanent deficits. In case of extended supracingular resection, supplementary motor area syndrome should be considered.

Entities:  

Mesh:

Year:  2012        PMID: 21946510     DOI: 10.1227/NEU.0b013e318237aaa3

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

Review 1.  Postoperative isolated lower extremity supplementary motor area syndrome: case report and review of the literature.

Authors:  Nardin Samuel; Brian Hanak; Jerry Ku; Ali Moghaddamjou; Francois Mathieu; Mahendra Moharir; Michael D Taylor
Journal:  Childs Nerv Syst       Date:  2019-11-09       Impact factor: 1.475

2.  Elimination of anxiety after laser interstitial thermal ablation of the dominant cingulate gyrus for epilepsy.

Authors:  Adrish Anand; Jay R Gavvala; Raissa Mathura; Ricardo A Najera; Ron Gadot; Ben Shofty; Sameer A Sheth
Journal:  Surg Neurol Int       Date:  2022-04-29

3.  Insights from the supplementary motor area syndrome in balancing movement initiation and inhibition.

Authors:  A R E Potgieser; B M de Jong; M Wagemakers; E W Hoving; R J M Groen
Journal:  Front Hum Neurosci       Date:  2014-11-28       Impact factor: 3.169

4.  Spiders, ladybugs and bees: A case of unusual sensations in a child with cingulate epilepsy.

Authors:  Robyn Whitney; Sameer AlMehmadi; Cristina Go; Ayako Ochi; Hiroshi Otsubo; Laura Bradbury; Kevin Jones; Eisha Christian; James Rutka; Bláthnaid McCoy
Journal:  Epilepsy Behav Case Rep       Date:  2017-04-29

5.  Application of MRI Post-processing in Presurgical Evaluation of Non-lesional Cingulate Epilepsy.

Authors:  Shan Wang; Bo Jin; Thandar Aung; Masaya Katagiri; Stephen E Jones; Balu Krishnan; Jorge A Gonzalez-Martinez; Richard A Prayson; Imad M Najm; Andreas V Alexopoulos; Shuang Wang; Meiping Ding; Zhong Irene Wang
Journal:  Front Neurol       Date:  2018-11-27       Impact factor: 4.003

6.  Optimization of surgical intervention outside the epileptogenic zone in the Virtual Epileptic Patient (VEP).

Authors:  Sora An; Fabrice Bartolomei; Maxime Guye; Viktor Jirsa
Journal:  PLoS Comput Biol       Date:  2019-06-26       Impact factor: 4.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.